Trump’s 200% Generic Drug Tariff Plan Puts India’s Pharma Exports in Focus
US President Donald Trump has announced a phased tariff policy on imported generic medicines, proposing duties of up to 200%…
Pharmaceutical Manufacturing
Read More
October 22, 2026
- Tamil Nadu Begins Dengue Vaccine Pilot Study in Tenkasi Under ICMR Supervision
- IMA Urges Centre to Review Film ‘SURYAA – Ant Se Aarambh Tak’ Over Portrayal of Doctors and Violence Against Healthcare Workers
- AIIMS Madurai to Begin Operations with 150 Beds in January 2027
- India’s Dedicated Medical Isotope Reactor in Visakhapatnam Likely to Begin Production by 2035